Group 1 - The core viewpoint of the article highlights the strong market response to the IPO of Zhuozheng Medical, with oversubscription exceeding 2700 times [1] - Zhuozheng Medical plans to issue 4.75 million shares globally, with 10% allocated for public offering in Hong Kong at a price of HKD 59.9, and is set to list on February 6 [1] - The company has a prestigious lineup of cornerstone investors, including Kingmed Diagnostics, He Xiaopeng (Chairman of Xiaopeng Motors), and several Tencent-affiliated tech firms, with Tencent being the largest institutional shareholder holding nearly 20% [1] Group 2 - Zhuozheng Medical focuses on the health service consumption market, emphasizing "evidence-based medicine and holistic healthcare" through a model that integrates physical locations and online services, providing comprehensive health management for families [1] - The company aims to maintain stable and sustainable financial performance by selecting high-frequency departments, launching a family membership system, and offering high-quality professional services, creating a stable growth cycle [1] - Zhuozheng Medical plans to leverage AI technology to empower its services, driving high-quality growth and transformative innovation following its IPO [1]